In addition, the three genes were also upregulated in A549 cisplatin-resistant cells and two of them (DUSP6, VEGFC) in A549 CSCs, further enforcing the relation between the cisplatin resistance and CSC potential in NSCLC cell lines. This evidence concerns the gene DUSP6 and non-small cell lung carcinoma.